EPIX

ESSA Pharma Inc · NASDAQ

Sector Health Technology
Industry Pharmaceuticals: Major
Website essapharma.com
Employees(FY) 50
ISIN CA29668H7085

Performance

-3.45%

-6.67%

-68.18%

-66.73%

-6.15%

YTD

-79.73%

Profile

ESSA Pharma Inc., a clinical stage pharmaceutical company, focuses the development of small molecule drugs for the treatment of prostate cancer. The company's lead candidate EPI-7386, an androgen receptor based resistance mechanisms that develop in patients with castration-resistant prostate cancer and metastatic castration-resistant prostate cancer. It has collaboration agreements with Bayer Consumer Care AG; Janssen Research & Development, LLC; and Astellas Pharma Inc. ESSA Pharma Inc. was incorporated in 2009 and is headquartered in Vancouver, Canada.

Advanced Technical Analysis

Technical Analysis of EPIX 2025-02-03

The stock indicators suggest a predominantly bearish sentiment, with a Moving Average Score of 3 indicating strong downward pressure, while the Oscillators Score of 43 reflects a neutral stance. However, the overall Technical Score of 8 reinforces the bearish outlook, signaling potential challenges ahead for the stock.

Technical Scores and Rating

Moving Average Score

Oscillator Score

Technical Rating

Stock Analysis of EPIX

Stock Rank

Recent News & Updates

2023-12-12 09:12
ESSA Pharma Inc (EPIX) Reports Fiscal Q4 and Full-Year Earnings, Advances in Prostate Cancer ...(GuruFocus.com)
2023-12-12 07:20
ESSA Pharma: Fiscal Q4 Earnings Snapshot(Associated Press Finance)
2023-12-12 07:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023(CNW Group)
2023-12-11 23:03
EPIX Stock Earnings: ESSA Pharma Beats EPS for Q4 2023(Investorplace)
2023-12-11 18:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023(Prnewswire)
2023-12-11 05:17
Bullish ESSA Pharma Insiders Loaded Up On US$1.19m Of Stock(Simply Wall St.)
2023-11-23 11:05
Director Franklin Berger Bolsters Position in ESSA Pharma Inc with Purchase of 23,259 Shares(GuruFocus.com)
2023-11-21 08:00
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference(PR Newswire)
2023-11-20 19:00
ESSA Pharma to Present at the Piper Sandler 35th Annual Healthcare Conference(Prnewswire)
2023-11-07 19:00
ESSA Pharma to Present at the Jefferies London Healthcare Conference(Prnewswire)
2023-11-06 04:51
ESSA Pharma Enters into At-The-Market Equity Offering Sales Agreement(Prnewswire)
2023-10-29 22:59
EPIX: Dose Escalation Data for Combination of Masofaniten (EPI-7386) and Enzalutamide Presented at PCF Retreat(Yahoo Finance)
2023-10-26 05:41
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 30th Annual Prostate Cancer Foundation Scientific Retreat(Yahoo Finance)
2023-10-20 21:00
ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the European Society of Medical Oncology 2023 Congress(Yahoo Finance)
2023-09-17 19:00
ESSA Pharma Announces Initiation of Phase 2 Study Evaluating Masofaniten (EPI-7386) in Combination with Enzalutamide in Patients with Metastatic Castration-Resistant Prostate Cancer(Yahoo Finance)
2023-08-30 19:00
ESSA Pharma Insiders Establish Automatic Securities Disposition Plans(Yahoo Finance)
2023-08-13 20:43
EPIX: Phase 2 Trial of EPI-7386 in Combination with Enzalutamide to Initiate in Calendar 3Q23(Yahoo Finance)
2023-08-07 19:17
ESSA Pharma: Fiscal Q3 Earnings Snapshot(Yahoo Finance)
2023-08-07 19:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Third Quarter Ended June 30, 2023(Yahoo Finance)
2023-06-05 19:00
ESSA Pharma Appoints Lauren Merendino to its Board of Directors(Yahoo Finance)
2023-05-31 19:00
ESSA Pharma to Present at 2023 Jefferies Healthcare Conference(Yahoo Finance)
2023-05-23 23:04
We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely(Yahoo Finance)
2023-05-17 18:25
EPIX: Moving Towards Phase 2 Trial of EPI-7386 in Combination with Enzalutamide(Yahoo Finance)
2023-05-10 19:00
ESSA Pharma to Present at JMP Securities Life Sciences Conference(Yahoo Finance)
2023-05-08 19:19
ESSA Pharma: Fiscal Q2 Earnings Snapshot(Yahoo Finance)
2023-05-08 19:00
ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Second Quarter Ended March 31, 2023(Yahoo Finance)
2023-04-17 19:00
ESSA Pharma to Present at the 2023 Bloom Burton & Co. Healthcare Investor Conference(Yahoo Finance)
2023-04-11 19:00
ESSA Pharma Announces Clinical Trial Support Agreement with Janssen to Evaluate EPI-7386 Combinations in Patients with Prostate Cancer(Yahoo Finance)
2023-03-07 18:00
ESSA Pharma to Present at the Oppenheimer 33rd Annual Healthcare Conference(Yahoo Finance)
2023-03-06 16:19
ESSA Pharma Inc.'s (NASDAQ:EPIX) recent 12% pullback adds to one-year year losses, institutional owners may take drastic measures(Yahoo Finance)

Page 2 of 4

previous next

Disclaimer: The information provided here and on kavout.com site is for general informational purposes only. It does not constitute investment advice, financial advice, trading advice, or any other sort of advice. Kavout does not recommend that any investment decision be made based on this information. You are solely responsible for your own investment decisions. Please conduct your own research and consult with qualified financial advisors before making any investment. Kavout and its partners are participants in a number of affiliate advertising programs. As an Amazon Associate, Kavout or its partners earn from qualifying purchases from affiliate links. We also participate in other affiliate and advertising programs that provide a means for us to earn advertising fees by advertising and linking to third-party websites.